Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer clinical trial (NCT01303029). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer clinical trial (NCT01303029). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer clinical trial (NCT01303029). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience severe side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer clinical trial (NCT01303029). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer clinical trial (NCT01303029). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel or logistical considerations I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer clinical trial (NCT01303029). Contact the study team or your healthcare provider for specific answers.

What this study is about